Charles River Laboratories (CRL) Tops Q3 EPS by 9c, Offers Guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $186.10 +2.50%
Revenue Growth %: -5.1%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -5.1%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.63, $0.09 better than the analyst estimate of $2.54. Revenue for the quarter came in at $989.2 million versus the consensus estimate of $974.65 million.
GUIDANCE:
Charles River Laboratories sees FY2022 EPS of $10.80-$10.95, versus the consensus of $10.80.
- Revenue growth, reported 10.0% – 11.0%
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
